Investing Profile

Albert Cha


Managing Partner at Frazier Healthcare Partners

Photo of Albert Cha, Managing Partner at Frazier Healthcare Partners

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
$100K - $5.0M
CompanyStageDateRound SizeTotal Raised
Silence Therapeutics
Post-IPO EquityNov 2021$20M
Olema Oncology
Series COct 2020$85M
Bristol Myers Squibb
Post-IPO EquityFeb 2017$80M
Co-investors: Peter Kolchinsky (RA Capital)
Aclaris Therapeutics
Series CSep 2015$40M
Series BOct 2014$21M
Series AOct 2012$21M
Co-investors: Ketan Patel (F-Prime Capital Partners)
Series ESep 2014$1M
Series EJun 2013$9M
Series DApr 2012$11M
Series DJan 2012$10M
Sierra Oncology
Series DApr 2014$60M
Co-investors: James N. Topper (Frazier Healthcare Partners)
TRIA Beauty
Private Equity RoundJul 2013$46M
Venture RoundOct 2012$7.5M
Series EJul 2008$30M
Co-investors: Frank Kung (Vivo Capital)
Ceptaris Therapeutics
Series DJun 2012$10M